AzTrials
AzTrials

Knee OsteoarthritisNCT06863181

Comparison of Conventional and Cooled Radiofrequency Ablation in Knee Osteoarthritis

A study testing Radiofrequency ablation in people with Knee Osteoarthritis, run by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study was to examine and compare the effects of conventional and cooled radiofrequency ablation on pain and disability levels in patients with knee pain resistant to other treatments due to knee osteoarthritis. Read more about this study

Who is it for?
Ages 50 to 80 years
Conditions the study is for
Knee Osteoarthritis
What is being tested?
Radiofrequency ablation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
26 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Feb 2025to 12 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Knee pain lasting more than 6 months
  • Age between 50 and 80
  • Diagnosis of radiographically proven grade III or IV knee osteoarthritis according to the Kellgren-Lawrence Grading Scale, marked narrowing of the medial compartment of the tibiofemoral joint space
  • Presence of pain resistant to conservative treatment
  • Exercise
  • Physical therapy agents
  • Use of oral anti-inflammatory agents

Who cannot join

  • History of trauma to the knee area
  • History of knee surgery
  • Presence of systemic inflammatory disease affecting the knee joint
  • Presence of peripheral neuropathy or radiculopathy
  • Pregnancy
  • Hemodynamic instability
Show all 10Show fewer
  • Presence of skin or soft tissue infection at the injection site
  • Refusal to participate in the study
  • Presence of acute knee pain with accompanying inflammatory findings
  • Presence of a serious psychiatric disorder or neurological disease Having received an intra-articular injection within the last 3 months

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gaziler Physical Medicine and Rehabilitation Training and Research Hospital

    Ankara, Çankaya, 06800

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of the Effectiveness of Conventional and Cooled Radiofrequency Ablation in Advanced Knee Osteoarthritis

The aim of this study was to examine and compare the effects of conventional and cooled radiofrequency ablation on pain and disability levels in patients with knee pain resistant to other treatments due to knee osteoarthritis.

Being tested
Radiofrequency ablation
Medical subject headings
Osteoarthritis, Knee

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Radiofrequency ablationDevice

    Genicular nerve neurolysis with heat

Study groups in NCT06863181
Study groupRoleWhat they receive
Conventional Radiofrequency AblationActive comparatorConventional radiofrequency ablation with fluoroscopy
Receives: Device: Radiofrequency ablation
Cooled Radiofrequency AblationExperimentalCooled radiofrequency ablation with ultrasound
Receives: Device: Radiofrequency ablation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analog Scale (VAS)

    Patients will select their pain from 10 mm scale

    Measured: Before treatment (0. week), 4 weeks after treatment (4.week), 12 weeks after treatment (12.week)

Secondary outcomes (3)
  1. Western Ontario and McMaster Universities Arthritis Index (WOMAC)

    This scale about patient's disability due to knee osteoarthritis

    Measured: Before treatment (0. week), 4 weeks after treatment (4.week), 12 weeks after treatment (12.week)

  2. 5-Point Likert Patient Satisfaction Scale

    '0' =I am not happy at all, '5'=I am very pleased

    Measured: Before treatment (0. week), 4 weeks after treatment (4.week), 12 weeks after treatment (12.week)

  3. Change in frequency of analgesic use

    How many analgesic did use in past week?

    Measured: Before treatment (0. week), 4 weeks after treatment (4.week), 12 weeks after treatment (12.week)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Mar 2025
  2. Study start1 Feb 2025
  3. Primary completion12 Aug 2025
  4. Study completion12 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06863181
Sponsor's protocol ID
AEŞH-EK-2025-064
Status last verified
Mar 2025
First submitted
3 Mar 2025
Last updated
27 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Radiofrequency ablation in people with Knee Osteoarthritis, run by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analog Scale (VAS) (time frame: Before treatment (0. week), 4 weeks after treatment (4.week), 12 weeks after treatment (12.week)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in